Tumors od neuroendrocrine origin MedDRA version: 14.1 Level: SOC Classification code 10022891 Term: Investigations System Organ Class: 10022891 - Investigations
Conditions
Interventions
Product Name: 68Ga-DOTA-NOC
Product Code: NA
Pharmaceutical Form: Solution for injection
INN or Proposed INN: NA
CAS Number: NA
Current Sponsor code: NA
Other descriptive name: NA
Concentration unit:
Sponsors
OSPEDALE SACRO CUORE-DON CALABRIA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age > 18 years; male or female; tumor of neuroendocrine origine Are the trial subjects under 18? no Number of subjects for this age range: 0 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 40 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 10
Exclusion criteria
Exclusion criteria: < 18 years; pregnancy; breast-feed; incapable to intend
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Diagnosys - Diagnosys of neuroendocrine tumors by PET with 68Ga-DOTANOC;Secondary Objective: Impact of the method in the definition of plain of treatment (hormone therapy vs chemiotherapy).;Primary end point(s): Number of lesions identified on CT vs number of lesions identified by PET with 68Ga-DOTANOC;Timepoint(s) of evaluation of this end point: NA | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): Impact of the method in the definition of plain of treatment (hormone therapy vs chemiotherapy).;Timepoint(s) of evaluation of this end point: NA | — |
Countries
Italy
Contacts
Public ContactNUCLEO RICERCA CLINICA c/o FARMACIA
OSPEDALE SACRO CUORE - DON CALABRIA
Outcome results
None listed